Mike Penning
Main Page: Mike Penning (Conservative - Hemel Hempstead)Department Debates - View all Mike Penning's debates with the Northern Ireland Office
(2 years, 9 months ago)
Commons ChamberThe hon. Gentleman gives a powerful example. Ballymurphy, which I spoke about at the Dispatch Box not that long ago, is another powerful example of it taking far too long in these situations for families to get answers and to get to the truth. I can be very clear with the House, as I have been before, that I am determined that the legislation we bring forward will allow families to get to the truth and understand what happened quicker than we have seen before. People should not be waiting decades for information.
British soldiers like myself were sent to Northern Ireland to keep the peace, and to put their lives on the line for the peace of everybody in Northern Ireland. I say to the Secretary of State that, while I welcome the Command Paper, we must not have any delay in the functions of Government getting to a conclusion on this, so that veterans—many of them have passed away already—can live their lives in peace, rather than in fear of being dragged before the courts.
My right hon. Friend makes an important point, from the point of view of veterans. He is absolutely right: most people who went out there served their country to protect life, in quite a contrast to the terrorists in Northern Ireland who went out every day to do harm. It is important that we deal with the issue, so that we do not leave it to another generation, and that we do so before we lose a generation who not only have information but deserve to live their final years in peace.
I thank the hon. Member for drawing this appalling case to the attention of the House. I can certainly assure him that he will be getting the meeting that he needs at the earliest opportunity.
I am delighted that my right hon. Friend has the meeting he wanted. We have already changed the law to allow doctors to prescribe cannabis products where clinically appropriate, but we are very keen to support this, provided that the Medicines and Healthcare products Regulatory Agency is happy as well.